Tumor characteristic | CD4+ count | Total | Mean CD4+ count ± SD | 95% CI | p-value | |
---|---|---|---|---|---|---|
≤350 | >350 | |||||
Cellular differentiation | ||||||
Well | 8 (66.7) | 4 (33.3) | 12 (100.0) | |||
Moderate | 5 (62.5) | 3 (37.5) | 8 (100.0) | |||
Poor | 2 (100.0) | 0 (0) | 2 (100.0) | |||
Total | 15 (68.2) | 7 (31.8) | 22 (100.0) | |||
Overall CD4 count n = 22 | 315.0 ± 138.0 | |||||
Well differentiated n = 12 | 318.8 ± 148.0 | |||||
Moderately and poorly differentiated n = 10 | 310 ± 132.8 | 0.893* | ||||
Cancer stage | ||||||
Early stage ( IA-IIA) | 5 (55.6) | 4 (44.4) | 9 (100.0) | 385.8 ± 170.4 | 354.8-516.7 | 0.042** |
Late stage (IIB-IVB) | 10 (76.9) | 3 (23.1) | 13 (100.0) | 266.2 ± 87.5 | 213.3-319.0 | |
Total | 15 (68.2) | 7 (31.8) | 22 (100.0) | 0.290 (Pearson)*** |